Hancock Jaffe

-$0.29 (-4.67%) As of 3:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Hancock Jaffe and other ETFs, options, and stocks.

About HJLI

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve.

CEO
Robert Andrew Berman
Employees
19
Headquarters
Irvine, California
Founded
1999

HJLI Key Statistics

Market Cap
53.45M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
109.66K
High Today
$6.19
Low Today
$5.96
Open Price
$6.19
Volume
50.53K
52 Week High
$20.25
52 Week Low
$4.99

HJLI Earnings

-$3.83
-$2.55
-$1.28
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure